{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:27:01Z","timestamp":1793413621443,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T00:00:00Z","timestamp":1407542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00401-014-1328-5","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T10:07:27Z","timestamp":1407492447000},"page":"679-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies"],"prefix":"10.1007","volume":"128","author":[{"given":"Mark","family":"Yarchoan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon B.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Arvanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Louneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.-Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon F.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,9]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s004010051014","volume":"97","author":"RA Armstrong","year":"1999","unstructured":"Armstrong RA, Cairns NJ, Lantos PL (1999) Quantification of pathological lesions in the frontal and temporal lobe of ten patients diagnosed with Pick\u2019s disease. Acta Neuropathol 97:456\u2013462","journal-title":"Acta Neuropathol"},{"key":"1328_CR2","author":"I Aviles-Olmos","year":"2012","unstructured":"Aviles-Olmos I, Limousin P, Lees A, Foltynie T (2012) Parkinson\u2019s disease, insulin resistance and novel agents of neuroprotection. Brain. doi: 10.1093\/brain\/aws009","journal-title":"Brain"},{"key":"1328_CR3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1073\/pnas.1119751109","volume":"109","author":"S Bang","year":"2012","unstructured":"Bang S, Kim S, Dailey MJ et al (2012) AMP-activated protein kinase is physiologically regulated by inositol polyphosphate multikinase. Proc Natl Acad Sci 109:616\u2013620. doi: 10.1073\/pnas.1119751109","journal-title":"Proc Natl Acad Sci"},{"key":"1328_CR4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/jnnp.2004.054445","volume":"76","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Wilson RS et al (2005) Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry 76:1194\u20131199. doi: 10.1136\/jnnp.2004.054445","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1328_CR5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS et al (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61:378\u2013384. doi: 10.1001\/archneur.61.3.378","journal-title":"Arch Neurol"},{"key":"1328_CR6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB et al (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers. J Clin Invest 122:1339\u20131353. doi: 10.1172\/JCI57256","journal-title":"J Clin Invest"},{"key":"1328_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IRA et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5\u201322. doi: 10.1007\/s00401-007-0237-2","journal-title":"Acta Neuropathol"},{"key":"1328_CR8","author":"S Craft","year":"2011","unstructured":"Craft S, Baker LD, Montine TJ et al (2011) Intranasal insulin therapy for alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. doi: 10.1001\/archneurol.2011.233","journal-title":"Arch Neurol"},{"key":"1328_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","volume":"3","author":"S Craft","year":"2004","unstructured":"Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3:169\u2013178. doi: 10.1016\/S1474-4422(04)00681-7","journal-title":"Lancet Neurol"},{"key":"1328_CR10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson DW, Bergeron C, Chin SS et al (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935\u2013946","journal-title":"J Neuropathol Exp Neurol"},{"key":"1328_CR11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157. doi: 10.1016\/S1474-4422(09)70238-8","journal-title":"Lancet Neurol"},{"key":"1328_CR12","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1073\/pnas.94.18.9660","volume":"94","author":"H Eldar-Finkelman","year":"1997","unstructured":"Eldar-Finkelman H, Krebs EG (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci 94:9660\u20139664","journal-title":"Proc Natl Acad Sci"},{"key":"1328_CR13","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1073\/pnas.94.18.9660","volume":"94","author":"H Eldar-Finkelman","year":"1997","unstructured":"Eldar-Finkelman H, Krebs EG (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. PNAS 94:9660\u20139664. doi: 10.1073\/pnas.94.18.9660","journal-title":"PNAS"},{"key":"1328_CR14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archneur.65.5.636","volume":"65","author":"F Geser","year":"2008","unstructured":"Geser F, Brandmeir NJ, Kwong LK et al (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65:636\u2013641. doi: 10.1001\/archneur.65.5.636","journal-title":"Arch Neurol"},{"key":"1328_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM et al (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 34:521\u2013533","journal-title":"Neuron"},{"key":"1328_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","volume":"65","author":"CA Grimes","year":"2001","unstructured":"Grimes CA, Jope RS (2001) The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391\u2013426","journal-title":"Prog Neurobiol"},{"key":"1328_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","volume":"147","author":"DP Hanger","year":"1992","unstructured":"Hanger DP, Hughes K, Woodgett JR et al (1992) Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 147:58\u201362. doi: 10.1016\/0304-3940(92)90774-2","journal-title":"Neurosci Lett"},{"key":"1328_CR18","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"JJ Hauw","year":"1994","unstructured":"Hauw JJ, Daniel SE, Dickson D et al (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015\u20132019","journal-title":"Neurology"},{"key":"1328_CR19","doi-asserted-by":"crossref","first-page":"E892","DOI":"10.1152\/ajpendo.00346.2002","volume":"284","author":"EJ Henriksen","year":"2003","unstructured":"Henriksen EJ, Kinnick TR, Teachey MK et al (2003) Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 284:E892\u2013E900. doi: 10.1152\/ajpendo.00346.2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1328_CR20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, Tuncman G, Chang L et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333\u2013336. doi: 10.1038\/nature01137","journal-title":"Nature"},{"key":"1328_CR21","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","volume":"272","author":"M Hong","year":"1997","unstructured":"Hong M, Lee VM-Y (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547\u201319553. doi: 10.1074\/jbc.272.31.19547","journal-title":"J Biol Chem"},{"key":"1328_CR22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 54:1916\u20131921","journal-title":"Neurology"},{"key":"1328_CR23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD et al (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J Neurosci 33:1024\u20131037. doi: 10.1523\/JNEUROSCI.2642-12.2013","journal-title":"J Neurosci"},{"key":"1328_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope RS, Johnson GVW (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95\u2013102. doi: 10.1016\/j.tibs.2003.12.004","journal-title":"Trends Biochem Sci"},{"key":"1328_CR25","first-page":"230","volume":"57","author":"T Kitamoto","year":"1987","unstructured":"Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230\u2013236","journal-title":"Lab Invest"},{"key":"1328_CR26","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","volume":"272","author":"X Li","year":"2005","unstructured":"Li X, Alafuzoff I, Soininen H et al (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer\u2019s disease brain. FEBS J 272:4211\u20134220. doi: 10.1111\/j.1742-4658.2005.04833.x","journal-title":"FEBS J"},{"key":"1328_CR27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco MV, Clarke JR, Frozza RL et al (2013) TNF-\u03b1 mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloid oligomers in mice and monkeys. Cell Metab 18:831\u2013843. doi: 10.1016\/j.cmet.2013.11.002","journal-title":"Cell Metab"},{"key":"1328_CR28","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"Q-L Ma","year":"2009","unstructured":"Ma Q-L, Yang F, Rosario ER et al (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078\u20139089. doi: 10.1523\/JNEUROSCI.1071-09.2009","journal-title":"J Neurosci"},{"key":"1328_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IRA Mackenzie","year":"2007","unstructured":"Mackenzie IRA, Bigio EH, Ince PG et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434. doi: 10.1002\/ana.21147","journal-title":"Ann Neurol"},{"key":"1328_CR30","doi-asserted-by":"crossref","first-page":"30981","DOI":"10.1016\/S0021-9258(18)47378-4","volume":"269","author":"M Mawal-Dewan","year":"1994","unstructured":"Mawal-Dewan M, Henley J, Van de Voorde A et al (1994) The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 269:30981\u201330987","journal-title":"J Biol Chem"},{"key":"1328_CR31","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872. doi: 10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"key":"1328_CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.10086","volume":"51","author":"TW Mitchell","year":"2002","unstructured":"Mitchell TW, Mufson EJ, Schneider JA et al (2002) Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer\u2019s disease. Ann Neurol 51:182\u2013189","journal-title":"Ann Neurol"},{"key":"1328_CR33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. doi: 10.1126\/science.1134108","journal-title":"Science"},{"key":"1328_CR34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","volume":"58","author":"JJ Pei","year":"1999","unstructured":"Pei JJ, Braak E, Braak H et al (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58:1010\u20131019","journal-title":"J Neuropathol Exp Neurol"},{"key":"1328_CR35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-110320","volume":"26","author":"C Ploia","year":"2011","unstructured":"Ploia C, Antoniou X, Sclip A et al (2011) JNK plays a key role in tau hyperphosphorylation in Alzheimer\u2019s disease models. J Alzheimers Dis 26:315\u2013329. doi: 10.3233\/JAD-2011-110320","journal-title":"J Alzheimers Dis"},{"key":"1328_CR36","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1074\/jbc.274.15.10625","volume":"274","author":"LY Qiao","year":"1999","unstructured":"Qiao LY, Goldberg JL, Russell JC, Sun XJ (1999) Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem 274:10625\u201310632","journal-title":"J Biol Chem"},{"key":"1328_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1348\/000711006X153051","volume":"61","author":"PH Ramsey","year":"2008","unstructured":"Ramsey PH, Ramsey PP (2008) Power of pairwise comparisons in the equal variance and unequal sample size case. Br J Math Stat Psychol 61:115\u2013131. doi: 10.1348\/000711006X153051","journal-title":"Br J Math Stat Psychol"},{"key":"1328_CR38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595\u20131607","journal-title":"Diabetes"},{"key":"1328_CR39","first-page":"247","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera EJ, Goldin A, Fulmer N et al (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019 s disease: link to brain reductions in acetylcholine. Insulin 8:247\u2013268","journal-title":"Insulin"},{"key":"1328_CR40","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1093\/brain\/awr308","volume":"134","author":"JL Robinson","year":"2011","unstructured":"Robinson JL, Geser F, Corrada MM et al (2011) Neocortical and hippocampal amyloid-\u03b2 and tau measures associate with dementia in the oldest-old. Brain 134:3708\u20133715. doi: 10.1093\/brain\/awr308","journal-title":"Brain"},{"key":"1328_CR41","first-page":"460","volume":"59","author":"ML Schmidt","year":"1988","unstructured":"Schmidt ML, Lee VM, Hurtig H, Trojanowski JQ (1988) Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer\u2019s disease. Lab Invest 59:460\u2013466","journal-title":"Lab Invest"},{"key":"1328_CR42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archgenpsychiatry.2010.48","volume":"67","author":"A Soetanto","year":"2010","unstructured":"Soetanto A, Wilson RS, Talbot K et al (2010) Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 67:448\u2013457. doi: 10.1001\/archgenpsychiatry.2010.48","journal-title":"Arch Gen Psychiatry"},{"key":"1328_CR43","first-page":"63","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? Insulin 7:63\u201380","journal-title":"Insulin"},{"key":"1328_CR44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang H, Kazi H et al (2012) Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316\u20131338. doi: 10.1172\/JCI59903","journal-title":"J Clin Invest"},{"key":"1328_CR45","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1074\/jbc.M112.435123","volume":"288","author":"Z Tang","year":"2013","unstructured":"Tang Z, Bereczki E, Zhang H et al (2013) mTor mediates tau dyshomeostasis: implication for Alzheimer disease. J Biol Chem 288:15556\u201315570. doi: 10.1074\/jbc.M112.435123","journal-title":"J Biol Chem"},{"key":"1328_CR46","doi-asserted-by":"crossref","unstructured":"The National Institute on Aging, Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. Neurobiol Aging 18:S1\u20132","DOI":"10.1016\/S0197-4580(97)00057-2"},{"key":"1328_CR47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","volume":"33","author":"JQ Trojanowski","year":"2007","unstructured":"Trojanowski JQ, Revesz T (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615\u2013620. doi: 10.1111\/j.1365-2990.2007.00907.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1328_CR48","first-page":"1101","volume":"2","author":"JR Wands","year":"2008","unstructured":"Wands JR (2008) Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed. Society 2:1101\u20131113","journal-title":"Society"},{"key":"1328_CR49","first-page":"1","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie L, Helmerhorst E, Taddei K et al (2002) Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 22:1\u20135","journal-title":"J Neurosci"},{"key":"1328_CR50","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db14-0287","volume":"63","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan M, Arnold SE (2014) Repurposing diabetes drugs for brain insulin resistance in alzheimer disease. Diabetes 63:2253\u20132261. doi: 10.2337\/db14-0287","journal-title":"Diabetes"},{"key":"1328_CR51","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/brain\/aws271","volume":"135","author":"M Yarchoan","year":"2012","unstructured":"Yarchoan M, Xie SX, Kling MA et al (2012) Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135:3749\u20133756. doi: 10.1093\/brain\/aws271","journal-title":"Brain"},{"key":"1328_CR52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351. doi: 10.1016\/j.neuron.2007.01.010","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-014-1328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-014-1328-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-014-1328-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:31Z","timestamp":1649894431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-014-1328-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1007\/s00401-014-1328-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,9]]}}}